Anne P. Frosch

Infectious Disease

701 Park Ave
Minneapolis, MN 55415

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Iron Deficiency and Neurobehavioral Outcomes in Ugandan Children Exposed to HIV.

Iron Deficiency and Neurobehavioral Outcomes in Ugandan Children Exposed to HIV.

Journal: The Journal of nutrition

Published: January 15, 2026

Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment.

Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment.

Journal: PloS one

Published: December 11, 2024

Viral Burden and Illness Severity During Acute SARS-CoV-2 Infection Predict Persistent Long COVID Symptoms.

Viral Burden and Illness Severity During Acute SARS-CoV-2 Infection Predict Persistent Long COVID Symptoms.

Journal: Open forum infectious diseases

Published: September 18, 2024

Effectiveness of Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19-Associated Hospitalization and Severe In-Hospital Outcomes Among Adults in the United States, September 2022-August 2023.

Effectiveness of Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19-Associated Hospitalization and Severe In-Hospital Outcomes Among Adults in the United States, September 2022-August 2023.

Journal: Influenza and other respiratory viruses

Published: July 17, 2024

Analysis of peripheral immune markers to predict liver injury during COVID-19.

Analysis of peripheral immune markers to predict liver injury during COVID-19.

Journal: Clinical journal of gastroenterology

Published: May 10, 2024

Safety and efficacy of iron supplementation with 3 months of daily ferrous sulphate in children living with HIV and mild-to-moderate anaemia in Uganda: a double-blind, randomised, placebo-controlled trial.

Safety and efficacy of iron supplementation with 3 months of daily ferrous sulphate in children living with HIV and mild-to-moderate anaemia in Uganda: a double-blind, randomised, placebo-controlled trial.

Journal: The lancet. HIV

Published: April 19, 2024

SARS-CoV-2 shedding and evolution in patients who were immunocompromised during the omicron period: a multicentre, prospective analysis.

SARS-CoV-2 shedding and evolution in patients who were immunocompromised during the omicron period: a multicentre, prospective analysis.

Journal: The Lancet. Microbe

Published: September 19, 2023

SARS-CoV-2 shedding and evolution in immunocompromised hosts during the Omicron period: a multicenter prospective analysis.

SARS-CoV-2 shedding and evolution in immunocompromised hosts during the Omicron period: a multicenter prospective analysis.

Journal: medRxiv : the preprint server for health sciences

Published: September 04, 2023

IL-15 Complex-Induced IL-10 Enhances Plasmodium-specific CD4+ T Follicular Helper Differentiation and Antibody Production.

IL-15 Complex-Induced IL-10 Enhances Plasmodium-specific CD4+ T Follicular Helper Differentiation and Antibody Production.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: August 04, 2023

Total and Subgenomic RNA Viral Load in Patients Infected With SARS-CoV-2 Alpha, Delta, and Omicron Variants.

Total and Subgenomic RNA Viral Load in Patients Infected With SARS-CoV-2 Alpha, Delta, and Omicron Variants.

Journal: The Journal of infectious diseases

Published: February 20, 2023

Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022.

Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022.

Journal: MMWR. Morbidity and mortality weekly report

Published: October 20, 2022

Neutralizing antibody responses in patients hospitalized with SARS-CoV-2 Delta or Omicron infection.

Neutralizing antibody responses in patients hospitalized with SARS-CoV-2 Delta or Omicron infection.

Journal: The Journal of clinical investigation

Published: October 18, 2022

Showing 1-12 of 36

Last Updated: 09/26/2026